Correlation Between Veracyte and Bio Path
Can any of the company-specific risk be diversified away by investing in both Veracyte and Bio Path at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Bio Path into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Bio Path Holdings, you can compare the effects of market volatilities on Veracyte and Bio Path and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Bio Path. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Bio Path.
Diversification Opportunities for Veracyte and Bio Path
Very weak diversification
The 3 months correlation between Veracyte and Bio is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Bio Path Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Path Holdings and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Bio Path. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Path Holdings has no effect on the direction of Veracyte i.e., Veracyte and Bio Path go up and down completely randomly.
Pair Corralation between Veracyte and Bio Path
Given the investment horizon of 90 days Veracyte is expected to generate 0.23 times more return on investment than Bio Path. However, Veracyte is 4.42 times less risky than Bio Path. It trades about -0.1 of its potential returns per unit of risk. Bio Path Holdings is currently generating about -0.19 per unit of risk. If you would invest 4,000 in Veracyte on December 28, 2024 and sell it today you would lose (890.00) from holding Veracyte or give up 22.25% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 61.67% |
Values | Daily Returns |
Veracyte vs. Bio Path Holdings
Performance |
Timeline |
Veracyte |
Bio Path Holdings |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Veracyte and Bio Path Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Veracyte and Bio Path
The main advantage of trading using opposite Veracyte and Bio Path positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Bio Path can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Path will offset losses from the drop in Bio Path's long position.Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |